Upcoming webinar

From surgery to surveillance: Managing referrals for germline and ctDNA testing

Date: Friday, September 25, 2026

Time: 9:00 AM PT | 12:00 PM ET (30-minute webinar)

Registrants will receive a recording of the webinar approximately one week after the event.

Join our panel of experts as they discuss the role of the surgeon in MRD testing:

Identify appropriate surgical patients for ctDNA and hereditary cancer testing based on clinical criteria and risk factors
The important role of ctDNA testing in post-surgical surveillance and how it complements other testing for a more comprehensive management strategy
Develop a referral pathway for hereditary cancer testing and ctDNA monitoring within their surgical practice or institution

Natera Honey Pot

Register Now:

First Name*

Last Name*

Email Address*

Job Title*

Phone*

Company Name*

Postal Code*

Country*

I am a*

Do you have any questions for the presenters that you would like to submit before the webinar?

Please fill in the field above only if you have specific questions. Otherwise, leave it blank.

Natera would like to send you information about our products and services. You may unsubscribe from these communications at any time.

Hear from our speakers:

David M. Hyams, MD, FACS

Surgical Oncologist

Desert Surgical Oncology

Luanna Labonte, MS, CGC

Medical Science Liaison

Natera

Abigail Ward, MS, LCGC

Medical Science Liaison

Natera

Signatera™ has been developed and its performance characteristics determined by the CLIA-certified laboratory performing the test. The test has not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2026 Natera, Inc. All Rights Reserved.

13011 McCallen Pass, Building A Suite 100 | Austin, TX 78753 | natera.com | Do Not Share My Personal Information | Privacy Policy